The Department of Health was alerted that Fresenius Kabi has Xylocaine with epinephrine presentations on shortage due to increased demand for the product and manufacturing delays and Pfizer has lidocaine with epinephrine presentations on shortage due to manufacturing delays.
You can read more about these shortages at:
